Skip to main content
. 2009 Mar 2;1:6. doi: 10.1186/1758-3284-1-6

Figure 1.

Figure 1

Signaling pathways frequently deregulated in HNSCC, the molecular targets involved and their corresponding inhibitors as potential anticancer agents.